The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant treatment and outcomes in patients with stage III colon cancer (CC) who do not fit clinical trial eligibility criteria (CTEC).
Khodadad Rasool Javaheri
No relevant relationships to disclose
Hagen F. Kennecke
No relevant relationships to disclose
Daniel John Renouf
No relevant relationships to disclose
Howard John Lim
No relevant relationships to disclose
Tina Hsu
No relevant relationships to disclose
Caroline Speers
No relevant relationships to disclose
Ozge Goktepe
No relevant relationships to disclose
Winson Y. Cheung
No relevant relationships to disclose